WeVote
Log In

Bill

Bill

SB 969

AN ACT CONCERNING PUBLIC DISCLOSURE OF CERTAIN INFORMATION REGARDING PHARMACEUTICAL REPRESENTATIVES.

2025 Regular Session Introduced by Heather Somers

SB 969 mandates public disclosure of pharmaceutical representatives' payments, gifts, and interactions with healthcare providers to increase transparency about industry influence on medical practice.

REF. TO JOINT COMM. ON General Law
#consumerprotectiondepartment #disclosure #electronicgovernmentinformation #pharmaceuticalindustry
0
WeVote Research Nonpartisan
Bill Summary · SB 969

Legislative bill overview

SB 969 would require public disclosure of information regarding pharmaceutical representatives' interactions with healthcare providers, including details about payments, gifts, and promotional activities. The bill aims to increase transparency in the pharmaceutical industry's marketing and relationship-building practices with medical professionals.

Why is this important

Pharmaceutical companies spend billions annually on marketing to doctors, which can influence prescribing practices and patient care decisions. Public disclosure requirements allow patients, researchers, and regulators to identify potential conflicts of interest and assess whether marketing practices may be driving inappropriate medication use or raising healthcare costs.

Potential points of contention

  • Industry burden and compliance costs: Pharmaceutical companies argue disclosure requirements create significant administrative overhead and may discourage legitimate medical education and professional interactions
  • Competitive concerns: Companies may resist disclosure of certain business information, claiming it reveals proprietary marketing strategies and competitive intelligence
  • Scope and definitions: Determining what constitutes a "gift" or "interaction" worth disclosing—such as meals at conferences, samples, or educational sponsorships—involves subjective judgment calls that could be interpreted inconsistently
  • Federal preemption: The Physician Payments Sunshine Law already requires federal disclosure; critics question whether state-level duplicative requirements add value or create conflicting standards

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.